Skip to main content

Antisense Oligonucleotides as Modulators of Pre-mRNA Splicing

  • Protocol
  • 475 Accesses

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 133))

Abstract

Antisense oligonucleotides have been extensively used as downregulators of gene expression (1), and as such are not only increasingly used in various fields as sequence-specific research tools (24), but are also tested in clinical trials as antiviral and anticancer agents (58).

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Crooke S. T. and Bennett CF. (1996) Progress in antisense oligonucleotide therapeutics. Ann. Rev. Pharm.Tox. 36, 107–129.

    Article  CAS  Google Scholar 

  2. Pasternak G. W. and Standifer K. M. (1995) Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16, 344–350.

    Article  PubMed  CAS  Google Scholar 

  3. Niggli E., Schwaller B., and Lipp P. (1996) Antisense oligodeoxynucleotides directed against the Na–Ca exchanger mRNA. Promising tools for studies on the cellular and molecular level. Ann. NY Acad. Sci. 779, 93–102.

    Article  PubMed  CAS  Google Scholar 

  4. Ramchandani S., MacLeod R. A., Pinard M., von Hoffe E., and Szyf M. (1997) Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 94, 684–689.

    Article  PubMed  CAS  Google Scholar 

  5. Zhang R., Y. J., Shahinian H., Amin G., Lu Z., Liu T., Saag M.S., Temsamani Y., and Martin R. R. (1995) Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIVinfected subjects. Clin. Pharm. Ther. 58, 44–53.

    Article  CAS  Google Scholar 

  6. Bishop, M. R., Iversen, P. L., Bayever, E., Shar, J. G., Greiner, T. C., Copple, et al. (1995) Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J. Clin. Oncol. 14, 1320–1326.

    Google Scholar 

  7. Agrawal, S (1996) Antisense oligonucleotides: towards clinical trials. Trends Biotech. 14, 376–378.

    Article  CAS  Google Scholar 

  8. Tonkinson, J. L. and Stein, C. A. (1996) Antisense oligonucleotides as clinical therapeutic agents. Cancer Invest. 14, 64–65.

    Article  Google Scholar 

  9. Dominski, Z. and Kole, R. (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 90, 8673–8677.

    Article  PubMed  CAS  Google Scholar 

  10. Sierakowska, H., Sambade, M. J., Agrawal, S., and Kole, R. (1996) Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA. 93, 12840–12844.

    Article  PubMed  CAS  Google Scholar 

  11. Weatherall, D. J. (1994) Thalassemias, in The Molecular Basis of Blood Diseases (Stamatoyannopoulos, G., et al., eds.), W.B. Saunders Philadelphia, pp. 157–205.

    Google Scholar 

  12. Mirabelli, C. K., and Crooke, S. T. (1993) Antisense oligonucleotides in the context of modern molecular drug discovery and development, in Antisense Research and Applications (Crooke, S. T. and Lebleu, B., eds.), CRC, Boca Raton, FL, pp. 7–35.

    Google Scholar 

  13. Furdon, P. F., Dominski, Z., and Kole, R. (1989) RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds. Nucleic Acids Res. 17, 9193–9204.

    Article  PubMed  CAS  Google Scholar 

  14. Sproat, B. S. and Lamond, A. I. (1993) 2′-O-alkyloligoribonucleotides, in Antisense Research and Applications (Crooke, S. T. and Lebleu, B., eds.), CRC, Boca Raton, FL, pp. 351–3

    Google Scholar 

  15. Zhang, R., Lu, Z., Zhao, H., Zhang, X., Diasio, R. B., Habus, I., et al. (1995) In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats. Biochem. Pharm. 50, 545–556.

    Article  PubMed  CAS  Google Scholar 

  16. Hawley-Nelson, P., Ciccarone, V., Gebeyehu, G., Jessee, J., and Felgner, P. L. (1993) Lipofectamine reagent: a new, higher efficiency polycationic liposome transfection reagent. Focus 15, 73–79.

    Google Scholar 

  17. Schagger, H. and von Jagov, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368–379.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Sierakowska, H., Agrawal, S., Kole, R. (2000). Antisense Oligonucleotides as Modulators of Pre-mRNA Splicing. In: Kmiec, E.B. (eds) Gene Targeting Protocols. Methods in Molecular Biology™, vol 133. Humana Press. https://doi.org/10.1385/1-59259-215-5:223

Download citation

  • DOI: https://doi.org/10.1385/1-59259-215-5:223

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-360-3

  • Online ISBN: 978-1-59259-215-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics